A historic shift in our drug policy has taken place, as the regulators permit the availability of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were heavily restricted, but a mounting body of studies suggests they could offer relief for psychological conditions like PTSD. This change represents a key step toward r